首页> 外文期刊>臨床病理 >The assessment of arteriolosclerosis by serum lipids data, and carotid ultrasonography and pulse wave velocity, and its evaluation as a tool for preventive medicine: II. Carotid ultrasonography and pulse wave velocity for hyperlipemia and diabetes me
【24h】

The assessment of arteriolosclerosis by serum lipids data, and carotid ultrasonography and pulse wave velocity, and its evaluation as a tool for preventive medicine: II. Carotid ultrasonography and pulse wave velocity for hyperlipemia and diabetes me

机译:血清脂质数据和颈动脉超声和脉搏波速度的动脉硬化评估及其作为预防医学工具的评价:II。 颈动脉超声和脉搏波速度和糖尿病患者

获取原文
获取原文并翻译 | 示例
           

摘要

We studied the test results of carotid ultrasonography and pulse wave velocity against a sample of hyperlipemia and diabetes mellitus. Sixty four hyperlipemia samples (HL), 85 diabetes mellitus samples (DS), and 27 complicated samples (CS) were compared with 56 healthy samples (HS). Hyperlipemia samples were selected from cholesterol under 300 mg/dl, and neutral fat under 300 mg/dl. Diabetes mellitus samples were selected from fasting plasma glucose (FBS) under 200 mg/dl. Samples from severe conditions with various disease were excluded. Ratio over 1.1 mm intima-media thickness (IMT) was 0% in HS, 48% in HL, 40% in DS and 33% in CS. PWV value was max 1896cm/s in CS. There was no significant correlation within IMT, serum lipid(Total Cholesterol, Neutral Fat, HDL-Cholesterol, LDL-Cholesterol) and FBS. For early treatment or accurate diagnosis of arteriosclerosis in hyperlipemia or diabetes mellitus patients, who are at high risk of developing arteriosclerosis, to vital function tests (carotid ultrasonography and pulse wave velocity) should be performed, in addition to normal blood tests.
机译:我们研究了对高脂血症和糖尿病样本的颈动脉超声和脉搏波速度的测试结果。将六十四个高脂血症样品(HL),85糖尿病样品(DS)和27个复杂的样品(CS)与56个健康样品(HS)进行比较。高脂血症样品选自300mg / dl下的胆固醇,中性脂肪下300mg / dl。糖尿病样品均由在200mg / dl的禁食血浆葡萄糖(FBS)中。排除了来自各种疾病的严重条件的样品。比率超过1.1mm内膜介质厚度(IMT)的HS,HL的48%,48%,40%,Cs中33%。 PWV值在CS中最多1896cm / s。 IMT,血清脂质(总胆固醇,中性脂肪,HDL-胆固醇,LDL-胆固醇)和FBS没有显着相关性。对于早期治疗或准确诊断在高氧化血症或糖尿病患者中,患有高风险的糖尿病患者,应当对正常血液测试进行重要功能试验(颈动脉超声和脉搏波速度)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号